FARM5210 – Novel Drug Delivery Systems (NDDS)
Course description
Schedule, syllabus and examination date
Course content
Learning outcome
After completing the course:
- you will have deep knowledge about the application of nanoparticles, bio conjugates, gels, and implants in drug delivery. Further, you will have a deep knowledge about novel technologies (e.g. theranostics, photochemical internalization) in drug targeting and in delivery of biomolecular drugs.
- you will have deep knowledge about in vitro challenges (e.g. drug load, solubility, stability, release profile) related to NDDS.
- You will have deep knowledge about in vivo challenges (e.g. biological barriers, physiological properties at the administration site, side effects, toxicology) related to NDDS.
- you will be able to discuss regulatory issues related to "quality and safety" upon application of NDDS.
- you will be able to work in a team, and prepare and present an overview on approaches for development of drug delivery systems for specific APIs.
- you will be able to communicate and discuss drug formulation aspects in a scientific forum.
Admission to the course
Formal prerequisite knowledge
Passed the exam in:
- FARM1100 – Pharmaceutical Chemistry
- FARM1110 – Pharmacology, Physiology and Cell Biology 1
- FARM1120 – Social Pharmacy
- FARM1130 – Pharmaceutically Based Organic Chemistry
- FARM1140 – Pharmacology, Physiology and Cell Biology 2
- FARM1150 – Pharmaceutical Based Biochemistry
- FARM2100 – Medicinal Chemistry
- FARM2110 – Pharmacotherapy 1
- FARM2120 – Pharmaceutics and Biopharmaceutics
- FARM2130 – Pharmaceutical Analytical Chemistry
- FARM2140 – Pharmaceutical Microbiology
- FARM2150 – Formulation of Drugs and Quality Assurance in Drug Production
- FARM3100 – Pharmacognosy
- FARM3110 – Pharmacotherapy 2 and Physiology 3
- FARM3120 – Medicine Use and Public Health
- FARM3130 – Advanced Pharmacy Practice Experience (APPE)
- the compulsory HMS-courses HMS0501 – Safety and Physical Environment, HMS0502 – Positive Learning Environment, HMS0503 – Laboratory Safety, HMS0506 – Patient Clinic Safety and HMS0507 – Fire Safety required for students at the 5-year Master`s Programme in Pharmacy.
Approved the compulsory parts of:
- FARM4100 – Personalised Drug Therapy
- FARM4110 – Comprehensive Biopharmacy and Formulation Technology
- FARM4120 – Drug Development
Formal prerequisite knowledge for students admitted to Studieløp for farmasøyter med mastergrad fra land utenfor EU/EØS:
- FARM4910K – Farmakoterapi og samfunnsfarmasi med fokus på norske terapitradisjoner og norske forhold
- FARM4920K – Fra virkestoff til ferdig formulering med fokus på avanserte legemiddelformer
- FARM4930K – Kvalitetssikring ved produksjon og klinisk utprøvning av legemidler
- approved the compulsory HMS-courses HMS0501 – Safety and Physical Environment, HMS0502 – Positive Learning Environment, HMS0503 – Laboratory Safety, HMS0506 – Patient Clinic Safety and HMS0507 – Fire Safety required for students at the 5-year Master`s Programme in Pharmacy.
Recommended previous knowledge
Overlapping courses
- 10 credits overlap with FRM5530 – Drug Formulation, Drug Targeting (discontinued).
Teaching
- 2 hours introduction (compulsory)
- 4 hours team work under supervision
- 15 hours team work in combination with flipped classroom to prepare mini lectures and poster
- 4 hours mini lectures (compulsory, pass/fail evaluation)
- 2 hours poster presentation (compulsory, pass/fail evaluation)
- 3 hours visit to pharmaceutical industry or similar (compulsory)
There is a compulsory attendance for the first information lecture. Students who do not meet are expected to have withdrawn from the course unless they have notified a valid due date to the Study Administration, studieinfo@farmasi.uio.no.
Compulsory participation in the course must be completed and compulsory submissions must be approved to pass the exam.
Read more about what applies in the event of absence from compulsory activities.
As the teaching involves laboratory and/or field work, you should consider taking out a separate travel and personal risk insurance. Read about your insurance cover as a student.
Access to teaching: A student who has completed compulsory instruction and coursework and has had these approved, is not entitled to repeat that instruction and coursework. A student who has been admitted to a course, but who has not completed compulsory instruction and coursework or had these approved, is entitled to repeat that instruction and coursework, depending on available capacity.
Compulsory participation and approved assignments are valid for 3 years.
The course may be cancelled, if the number of enrolled students are low.
Examination
Final written exam, which counts 100 % towards the finale grade.
Mini lectures, poster preparation and -presentation should be approved prior to the exam.
It will also be counted as one of the three attempts to sit the exam for this course, if you sit the exam for one of the following courses: FRM5530 – Drug Formulation, Drug Targeting (discontinued)
Examination support material
Language of examination
Grading scale
Resit an examination
This course offers both postponed and resit of examination. Read more:
More about examinations at UiO
- Use of sources and citations
- How to use AI as a student
- Special exam arrangements due to individual needs
- Withdrawal from an exam
- Illness at exams / postponed exams
- Explanation of grades and appeals
- Resitting an exam
- Cheating/attempted cheating
You will find further guides and resources at the web page on examinations at UiO.